PCV72 COST-EFFECTIVENESS OF EXTENDED-RELEASE NICOTINIC ACID/ LAROPIPRANT AS MONOTHERAPY VERSUS EZETIMIBE MONOTHERAPY IN PATIENTS WITH MIXED DYSLIPIDAEMIA IN SCOTLAND

Saved in:
Bibliographic Details
Published inValue in health Vol. 13; no. 7; p. A354
Main Authors Jameson, K, Davies, GM, Ambegaonkar, BM, Sazonov, V, O'Regan, C
Format Journal Article
LanguageEnglish
Published Elsevier Inc 2010
Subjects
Internal Medicine
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/S1098-3015(11)72415-9